Clinical characteristics and intravitreal aflibercept outcomes in patients aged 90 years and older with neovascular age-related macular degeneration

In the very elderly patient group, nAMD can lead to severe damage in the macula, and a decrease in visual acuity despite treatment is not uncommon. Close monitoring and support for treatment adherence are necessary for this group of patients.

Authors

Institutions

Publication Details

Journal
BMC Geriatrics
Published
2024-12-19
DOI
https://doi.org/10.1186/s12877-024-05596-9
Citations
1
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.54
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical characteristics and intravitreal aflibercept outcomes in patients aged 90 years and older with neovascular age-related macular degeneration

Feyzahan Ekici
1 citations
BMC Geriatrics
Retinal Diseases and Treatments
0.54
article

Clinical characteristics and intravitreal aflibercept outcomes in patients aged 90 years and older with neovascular age-related macular degeneration

Feyzahan Ekici
article en
1 citations

Abstract

In the very elderly patient group, nAMD can lead to severe damage in the macula, and a decrease in visual acuity despite treatment is not uncommon. Close monitoring and support for treatment adherence are necessary for this group of patients.

BMC GeriatricsVol. 24(1)
Recep Tayyip Erdoğan University (TR)
Zero hunger
Openalex Percentile: Top 29%
Retinal Diseases and Treatments
0.54
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Clinical characteristics and intravitreal aflibercept outcomes in patients aged 90 years and older with neovascular age-related macular degeneration — Feyzahan Ekici · BMC Geriatrics (2024) | TGRS Research Map | TGRS